SCD Study Seeks Participants

Your participation can contribute to advancing knowledge and improving care for individuals with sickle cell disease (SCD). The study aims to enhance the understanding of SCD and its associated complications by investigating the relationship between the disease and specific variations of certain genes. If you have SCD, your participation in this study is highly valuable.

By participating, you will undergo an evaluation and receive recommendations from a team experienced in the treatment and management of SCD. To inquire about participating in the study, please contact the NIH Office of Patient Recruitment at 866-444-8810 or ccopr@nih.gov. Refer to the NIH study number #04-H-0161. You can also find more information about the study at the following link: https://go.nih.gov/6ddLFWJ.

Volunteers Needed for Endometrial Cancer Study

Researchers from NIH’s National Cancer Institute are currently looking for patients with HER2-expressing endometrial cancer, a type of cancer in the uterus.

The purpose of the research study is to test two investigational study drugs—a vaccine that targets HER2 (AdHER2DC) that is made out of the patient’s own blood cells and an additional investigational drug that is suggested to help the immune cells destroy tumor cells (N-803). Both of these drugs will be combined with two FDA-approved cancer treatment drugs that are used for patients with endometrial cancer.

Research procedures will be provided at no cost, and travel assistance may also be provided. If you’re interested, please contact 866-444-8810 or ccopr@nih.gov and refer to the study number #001557-C. To learn more, visit https://go.nih.gov/NEJnMuT.